AVVA Pharmaceuticals is a Pharmaceutical company, Manufacturer/Innovator company operating in the pharmaceutical industry.
AVVA Pharmaceuticals Ltd is a European based pharmaceutical company, aiming on becoming a reference innovation hub for the development of biological medicines and new small molecules, with ultimate goal on providing a meaningful and affordable healthcare. The company focuses on developing biosimilars and biological medicines in partnership with leading international research and scientific centers. Our portfolio includes a number of inventions that will replace current standards in the fields of infectious and metabolic diseases.
Company type
Pharmaceutical company, Manufacturer/Innovator
Products and services
Pharmaceutical Products / ATC coding, Biopharmaceuticals
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Address
AVVA Pharmaceuticals, 23A Spirou Kyprianou, Limassol, Cyprus, 4001
